Advertisement
Home Blog Page 35

Elinzanetant Safe, Effective for Moderate-to-Severe Vasomotor Symptoms

0

Benefits seen in frequency and severity, as well as menopause-related quality of life

GLP-1 Receptor Agonists Tied to Reduced Mortality in Patients With Psoriasis

0

Risk reductions stronger in those with psoriasis versus those with obesity or type 2 diabetes without psoriasis

Heat May Modify Impact of Toxic Metal(loid)s on Kidney Health

0

Chronic heat exposure exacerbates the effects of arsenic and cadmium; no significant interactions seen for acute heat stress

Odds of Repeat Imaging Higher for Nonphysician Practitioner Interpretation

0

Findings consistent across imaging modalities compared with radiologist interpretation

Study Chronicles War-Related Injuries in Gaza

0

Explosive injuries accounted for two-thirds of weapon-related trauma

Self-Reported Cognitive Disability Rates Increased in U.S. Adults From 2013 to 2023

0

Disproportionate growth in cognitive disability among younger adults ages 18 to 39 years drove overall national trend

Adherence to ACS Guideline Linked to Lower Mortality in Nonmetastatic Prostate Cancer

0

Lower mortality risk seen for those who improved guideline concordance after diagnosis or maintained high concordance

AAP: Pediatric Golf Cart-Related Injuries Mainly Caused by Falls

0

The most common injuries were those to the head, face, and neck regions; these were likely to be caused due to fall

FDA Approves Opzelura for Atopic Dermatitis in Children

0

It is the first topical JAK inhibitor approved in the U.S. for pediatric atopic dermatitis

Kennedy Says FDA Reviewing Safety of Abortion Pill Mifepristone

0
By Deanna Neff HealthDay Reporter MONDAY, Sept. 29, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) is reviewing the safety of mifepristone,...